Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueCurrent LeasesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sensus Healthcare (SRTS) Non-Current Assets (2016 - 2025)

Historic Non-Current Assets for Sensus Healthcare (SRTS) over the last 10 years, with Q3 2025 value amounting to $8.1 million.

  • Sensus Healthcare's Non-Current Assets rose 6013.46% to $8.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $26.2 million, marking a year-over-year increase of 6067.31%. This contributed to the annual value of $5.4 million for FY2024, which is 2977.04% up from last year.
  • Per Sensus Healthcare's latest filing, its Non-Current Assets stood at $8.1 million for Q3 2025, which was up 6013.46% from $6.6 million recorded in Q2 2025.
  • Sensus Healthcare's 5-year Non-Current Assets high stood at $8.1 million for Q3 2025, and its period low was $995000.0 during Q4 2021.
  • Over the past 5 years, Sensus Healthcare's median Non-Current Assets value was $4.3 million (recorded in 2023), while the average stood at $4.2 million.
  • In the last 5 years, Sensus Healthcare's Non-Current Assets tumbled by 6495.24% in 2021 and then skyrocketed by 25115.58% in 2022.
  • Over the past 5 years, Sensus Healthcare's Non-Current Assets (Quarter) stood at $995000.0 in 2021, then soared by 251.16% to $3.5 million in 2022, then grew by 19.69% to $4.2 million in 2023, then grew by 29.77% to $5.4 million in 2024, then surged by 49.07% to $8.1 million in 2025.
  • Its last three reported values are $8.1 million in Q3 2025, $6.6 million for Q2 2025, and $6.0 million during Q1 2025.